Canopy Growth Corp continues to invest for the future, GMP says

Despite middling first quarter results, GMP Securities analyst Martin Landry is sticking to his guns on Canopy Growth Corp. (Canopy Growth Stock Quote, Chart, News: TSX:WEED).

On Monday, Canopy Growth reported its Q1, 2018 results. The company lost $4.44-million on revenue of $15.9-million, a topline bump of 127 per cent over the same period last year.

“Our focus in the first half of calendar 2017 has been preparing our business to lead the legal recreational market that is set to open in Canada in 2018, while continuing to be the clear leader in the ongoing medical market,” said CEO Bruce Linton. “Believing business to consumer e-commerce sales will form the backbone of the Canadian cannabis market in 2018 and beyond, we have taken deliberate steps this year to stress our platform and in some cases break it, all as part of a warm-up exercise.

Landry notes that the quarter met his expectations, but fell below the street consensus. The analyst says he is lowering his fiscal 2018 forecasts to reflect recent trends of lower consumption by patients, a shift towards lower-priced Tweed Farm products, and elevated SG&A investment. But the analyst is maintaining his “Buy” rating and one-year price target of $11.00 on Canopy Growth Corp, pointing out that the dominant factor of quarter was the company’s continued investment in its future.

“As expected, Canopy’s Q1 results were somewhat muted, reflecting the transitory period for Mettrum’s facility, consolidation of retail platforms, and limited oil products available for sale,” he says. “The trend in rising OPEX is somewhat concerning, as it is expected to continue thus limiting our visibility as to when the company could begin to generate higher operating leverage. Despite the above, with the new extraction system in place, WEED’s sizable inventories suggest a solid runway for growth in extract sales going forward. Our target is derived from a DCF analysis assuming: (1) a discount rate of 9%, (2) two-stage average revenue growth of 22% and EBITDA margin of 23% (unchanged), and (3) terminal growth of 3%.”

Landry thinks Canopy will generate EBITDA of negative $7.5-million on revenue of $84.9-million in fiscal 2018. He expects those numbers will improve to EBITDA of positive $24.5-million on a topline of $172.9-million the following year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

4 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

11 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

12 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

13 hours ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

1 day ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

1 day ago